216 related articles for article (PubMed ID: 37414154)
21. Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease intervention.
Zhao L; Teter B; Morihara T; Lim GP; Ambegaokar SS; Ubeda OJ; Frautschy SA; Cole GM
J Neurosci; 2004 Dec; 24(49):11120-6. PubMed ID: 15590928
[TBL] [Abstract][Full Text] [Related]
22. Age-Related Increase of Insulin-Degrading Enzyme Is Inversely Correlated with Cognitive Function in APPswe/PS1dE9 Mice.
Zhang Y; Wang P
Med Sci Monit; 2018 Apr; 24():2446-2455. PubMed ID: 29680859
[TBL] [Abstract][Full Text] [Related]
23. Effects of ageing and experimental diabetes on insulin-degrading enzyme expression in male rat tissues.
Kochkina EG; Plesneva SA; Vasilev DS; Zhuravin IA; Turner AJ; Nalivaeva NN
Biogerontology; 2015 Aug; 16(4):473-84. PubMed ID: 25792373
[TBL] [Abstract][Full Text] [Related]
24. Identification and functional characterization of a putative IDE, C28F5.4 (ceIDE-1), in Caenorhabditis elegans: Implications for Alzheimer's disease.
Haque R; Nazir A
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2454-2462. PubMed ID: 27443962
[TBL] [Abstract][Full Text] [Related]
25. Perindopril ameliorates experimental Alzheimer's disease progression: role of amyloid β degradation, central estrogen receptor and hyperlipidemic-lipid raft signaling.
Messiha BAS; Ali MRA; Khattab MM; Abo-Youssef AM
Inflammopharmacology; 2020 Oct; 28(5):1343-1364. PubMed ID: 32488543
[TBL] [Abstract][Full Text] [Related]
26. Toward Allosterically Increased Catalytic Activity of Insulin-Degrading Enzyme against Amyloid Peptides.
Kurochkin IV; Guarnera E; Wong JH; Eisenhaber F; Berezovsky IN
Biochemistry; 2017 Jan; 56(1):228-239. PubMed ID: 27982586
[TBL] [Abstract][Full Text] [Related]
27. High Fat Diet Aggravates AD-Related Pathogenic Processes in APP/PS1 Mice.
Gong X; Liang Z; Liu W; Zhao Y; Yang Y; Wu M; Shang J; Xiao Y; Mei Y; Su Q; Sun B; Bao J; Shu X
Curr Alzheimer Res; 2021; 18(4):310-325. PubMed ID: 34212829
[TBL] [Abstract][Full Text] [Related]
28. Insulin-degrading enzyme: a link between Alzheimer's and type 2 diabetes mellitus.
Haque R; Nazir A
CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):259-64. PubMed ID: 24059320
[TBL] [Abstract][Full Text] [Related]
29. The Longest Amyloid-β Precursor Protein Intracellular Domain Produced with Aβ42 Forms β-Sheet-Containing Monomers That Self-Assemble and Are Proteolyzed by Insulin-Degrading Enzyme.
Krasinski CA; Zheng Q; Ivancic VA; Spratt DE; Lazo ND
ACS Chem Neurosci; 2018 Dec; 9(12):2892-2897. PubMed ID: 30067897
[TBL] [Abstract][Full Text] [Related]
30. Elevated glucose and oligomeric β-amyloid disrupt synapses via a common pathway of aberrant protein S-nitrosylation.
Akhtar MW; Sanz-Blasco S; Dolatabadi N; Parker J; Chon K; Lee MS; Soussou W; McKercher SR; Ambasudhan R; Nakamura T; Lipton SA
Nat Commun; 2016 Jan; 7():10242. PubMed ID: 26743041
[TBL] [Abstract][Full Text] [Related]
31. Characteristics of Insulin-degrading Enzyme in Alzheimer's Disease: A Meta-Analysis.
Zhang H; Liu D; Huang H; Zhao Y; Zhou H
Curr Alzheimer Res; 2018; 15(7):610-617. PubMed ID: 29357797
[TBL] [Abstract][Full Text] [Related]
32. Insulysin: an allosteric enzyme as a target for Alzheimer's disease.
Song ES; Hersh LB
J Mol Neurosci; 2005; 25(3):201-6. PubMed ID: 15800373
[TBL] [Abstract][Full Text] [Related]
33. Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain.
Wang S; Wang R; Chen L; Bennett DA; Dickson DW; Wang DS
J Neurochem; 2010 Oct; 115(1):47-57. PubMed ID: 20663017
[TBL] [Abstract][Full Text] [Related]
34. Effect of growth differentiation factor-15 secreted by human umbilical cord blood-derived mesenchymal stem cells on amyloid beta levels in in vitro and in vivo models of Alzheimer's disease.
Kim DH; Lee D; Lim H; Choi SJ; Oh W; Yang YS; Chang JH; Jeon HB
Biochem Biophys Res Commun; 2018 Oct; 504(4):933-940. PubMed ID: 30224067
[TBL] [Abstract][Full Text] [Related]
35. Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme.
Vekrellis K; Ye Z; Qiu WQ; Walsh D; Hartley D; Chesneau V; Rosner MR; Selkoe DJ
J Neurosci; 2000 Mar; 20(5):1657-65. PubMed ID: 10684867
[TBL] [Abstract][Full Text] [Related]
36. Insulin-Degrading Enzyme in the Fight against Alzheimer's Disease.
Kurochkin IV; Guarnera E; Berezovsky IN
Trends Pharmacol Sci; 2018 Jan; 39(1):49-58. PubMed ID: 29132916
[TBL] [Abstract][Full Text] [Related]
37. (Pre)diabetes, brain aging, and cognition.
S Roriz-Filho J; Sá-Roriz TM; Rosset I; Camozzato AL; Santos AC; Chaves ML; Moriguti JC; Roriz-Cruz M
Biochim Biophys Acta; 2009 May; 1792(5):432-43. PubMed ID: 19135149
[TBL] [Abstract][Full Text] [Related]
38. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation.
Qiu WQ; Walsh DM; Ye Z; Vekrellis K; Zhang J; Podlisny MB; Rosner MR; Safavi A; Hersh LB; Selkoe DJ
J Biol Chem; 1998 Dec; 273(49):32730-8. PubMed ID: 9830016
[TBL] [Abstract][Full Text] [Related]
39. Protective Effect of Notoginsenoside R1 on an APP/PS1 Mouse Model of Alzheimer's Disease by Up-Regulating Insulin Degrading Enzyme and Inhibiting Aβ Accumulation.
Li Z; Li H; Zhao C; Lv C; Zhong C; Xin W; Zhang W
CNS Neurol Disord Drug Targets; 2015; 14(3):360-9. PubMed ID: 25714973
[TBL] [Abstract][Full Text] [Related]
40. Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein.
Farris W; Mansourian S; Leissring MA; Eckman EA; Bertram L; Eckman CB; Tanzi RE; Selkoe DJ
Am J Pathol; 2004 Apr; 164(4):1425-34. PubMed ID: 15039230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
